Funded in partnership with the American Association for Cancer Research (AACR), our new Transatlantic Fellowships provide high-potential early-career researchers with a unique opportunity to accelerate their careers. The Fellowships offer £300,000/$400,000 over four years to support the development of recently graduated PhDs and early-career postdocs into independent researchers at top institutions in the United Kingdom and the United States.
Read More
One late summer morning, I recall seeing a petite woman carrying two suitcases near the entrance to a hospital. She was alone and seemed indifferent to the commotion enveloping her.
This instance was mere moments long, yet it is ingrained in my memory. Because nearly six years ago, when I entered our cancer hospital on my first day as a doctoral student in cancer biology, this was exactly what I saw. I saw a woman, carrying her most precious belongings as she checked into the hospital for cancer treatment.
As I offered to help with her luggage, she kindly obliged and asked to share with me her story. Why? She wanted “at least one person to remember” her. And she got her wish, before succumbing to her disease two weeks later.
Read More
Last year, the U.S. Food and Drug Administration approved 15 new anticancer therapeutics. More groundbreaking treatments are on the way. Despite this progress, cancer still has a disproportionate impact on disadvantaged and minority groups.
Read More
“We are in a promising time for cancer research and treatment; however, ovarian cancer remains difficult to treat, since it is often not detected until it has reached an advanced …
Read More
The American Association for Cancer Research (AACR) is proud to support the Scientist↔Survivor Program (SSP), which provides cancer survivors with opportunities to engage in cancer research, survivorship issues, advocacy, and …
Read More
Each year, the American Association for Cancer Research (AACR) is proud to bring Associate Members to Washington, D.C., where they meet with legislators and policymakers to discuss issues that are critical to supporting medical research.
Read MoreA recent blog post by the Sidney Kimmel Cancer Center – Jefferson Health examined whether the power of immunotherapy can be used to treat pancreatic cancer. The blog featured a …
Read MoreEditor’s note: February is Cancer Prevention Month. That’s why the American Association for Cancer Research (AACR) has been pleased to support the American Institute for Cancer Research (AICR) Cancer Prevention: Together We Can campaign, an initiative dedicated to promoting evidence-based information to reduce cancer risk. This blog post was developed and shared by the AICR.
Read More
The field of medical oncology is undergoing a remarkable transformation. Cancers that were once considered death sentences, such as multiple myeloma and metastatic melanoma, are turning into chronic diseases due to the use of novel, targeted systemic therapies. Immunotherapy is altering the natural history of certain malignancies.
Read More
The relationship between cigarette smoking and lung cancer was first brought to the public’s attention more than 50 years ago, when the U.S. Surgeon General’s report on “Smoking and Health” was published. However, tobacco companies are only now telling the truth about their deadly products, and only thanks to a 2006 court order that they spent more than a decade trying to overturn.
Read More